INTERNATIONAL PATENT: CHENGDU ZENITAR BIOMEDICAL TECHNOLOGY CO., LTD., 成都赜灵生物医药科技有限公司 FILES APPLICATION FOR "QUINAZOLINE DERIVATIVE RIPK2 INHIBITOR AND USE THEREOF"

Posted On: 2025-05-11

GENEVA, May 11 -- CHENGDU ZENITAR BIOMEDICAL TECHNOLOGY CO., LTD. (9F, No.3 Building, No. 16 Hemin Street, China (Sichuan) Pilot Free Trade Zone, Hi-Tech ZoneChengdu, Sichuan 610000), 成都赜灵生物医药科技有限公司 (中国四川省成都市中国（四川）自由贸易试验区成都高新区和民街16号3号楼9F) filed a patent application (PCT/CN2024/128515) for "QUINAZOLINE DERIVATIVE RIPK2 INHIBITOR AND USE THEREOF" on Oct 30, 2024. With publication no. WO/2025/092821, the details related to the ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: CHENGDU ZENITAR BIOMEDICAL TECHNOLOGY CO., LTD., 成都赜灵生物医药科技有限公司 FILES APPLICATION FOR "QUINAZOLINE DERIVATIVE RIPK2 INHIBITOR AND USE THEREOF"